Clinical Trial

Remimazolam TIVA-Flumazenil Antagonism in Short-duration ENT Surgeries

Study acronym: TIVA
Completed
View on ClinicalTrials.gov →
Summary
This study plans to categorize patients who underwent short-duration ENT surgeries with remimazolam TIVA combined with flumazenil antagonism based on whether their intraoperative BIS values were maintained below 60.
Protocol Amendment History 2 changes
critical Trial status changed: Not Yet Recruiting → Completed 2026-05-12
notable Enrollment reduced: 600 -> 511 participants 2026-05-12
Trial Details
NCT Number NCT07389798
Lead Sponsor Tongji Hospital
Conditions Remimazolam, Total Intravenous Anesthesia, Bispectral Index
Enrollment 511 participants
Start Date 2026-03-09
Primary Completion 2026-03-29 (estimated)
Study Completion 2026-04-04 (estimated)
Updated on ClinicalTrials.gov 2026-05-11